Variable | Total (N = 105) | Ovarian Cancer (N = 37) | Benign (N = 22) | Normal control (N = 46) | P Value |
---|---|---|---|---|---|
Age (years) |  |  |  |  | < 0.001 |
 N | 105 | 37 | 22 | 46 |  |
 Mean ± SD | 46.7 ± 13.8 | 53.4 ± 12.8 | 37.4 ± 11.7 | 41.2 ± 12.1 |  |
 Min–Max | 18.0–74.0 | 20.0–74.0 | 20.0–70.0 | 18.0–68.0 |  |
 Median(Q1-Q3) | 46.0(32.0–54.0) | 53.0(47.0–66.0) | 36.0(28.0–44.5) | 38.5(31.3–51.0) |  |
BMI (kg/m2) | Â | Â | Â | Â | 0.618 |
 N | 105 | 37 | 22 | 46 |  |
 Mean ± SD | 22.5 ± 2.9 | 22.2 ± 2.7 | 22.5 ± 2.4 | 22.8 ± 3.2 |  |
 Min–Max | 16.0–30.0 | 17.5–27.9 | 18.4–28.2 | 16.0–30.0 |  |
 Median(Q1-Q3) | 22.4(20.3–24.1) | 21.8(20.2–24.1) | 22.6(21.2–23.4) | 22.4(20.3–25.5) |  |
OV | |||||
 Serous (%) | 33(89.2) | 33(89.2) | N/A | N/A |  |
 Mucinous (%) | 2(5.4) | 2(5.4) | N/A | N/A |  |
 Endometrioid (%) | 1(2.7) | 1(2.7) | N/A | N/A |  |
 Others (%) | 1(2.7) | 1(2.7) | N/A | N/A |  |
FIGOÂ stage | Â | Â | N/A | N/A | Â |
 IA(%) | 1(2.7) | 1(2.7) | N/A | N/A |  |
 IC(%) | 8(21.6) | 8(21.6) | N/A | N/A |  |
 IIB(%) | 1(2.7) | 1(2.7) | N/A | N/A |  |
 III(%) | 2(5.4) | 2(5.4) | N/A | N/A |  |
 IIIA(%) | 2(5.4) | 2(5.4) | N/A | N/A |  |
 IIIC(%) | 20(54) | 20(54) | N/A | N/A |  |
 IV(%) | 2(5.4) | 2(5.4) | N/A | N/A |  |
 IVB(%) | 1(2.7) | 1(2.7) | N/A | N/A |  |